Whole genome sequencing (WGS), the process of determining the complete nucleotide or DNA/RNA sequence of a genome at one time, has made headlines recently for its potential to transform infectious disease management, particularly related to SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Laboratories around the world have paused regular work to pursue treatment for COVID-19. While there are still no evidence-based treatments available, scientists are evaluating a variety of options beyond supportive care.
Researchers from MIT and Harvard developed a new approach to antibiotic discovery using a type of artificial AI called deep learning. So far, their model has identified eight antibacterial compounds that differ in structure from known antibiotics.
Throughout 2019, the transformation of diagnostic technology has been centered around machine learning, maximizing patient value, and the needs of those with chronic ailments and diseases. As technology advances, so does the ability to diagnose and treat, whether in the ICU or over the phone.